Expert Review of Anticancer Therapy 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Efficacy and safety of neoadjuvant combination immunotherapy in surgically resectable malignant solid tumors: a systematic review and meta-analysis
CONCLUSION: This study demonstrated the efficacy of neoadjuvant combination immunotherapy. Given that the majority of the included trials were phase II with small sample sizes, further multicenter phase III randomized controlled trials should be conducted to validate the findings of the review.PMID:38436076 | DOI:10.1080/14737140.2024.2325404 (Source: Expert Review of Anticancer Therapy)
Source: Expert Review of Anticancer Therapy - March 4, 2024 Category: Cancer & Oncology Authors: Yuqian Feng Kaibo Guo Huimin Jin Jing Jiang Menglei Wang Shengyou Lin Source Type: research
Racial and socioeconomic disparities in triple-negative breast cancer treatment
Expert Rev Anticancer Ther. 2024 Mar 4. doi: 10.1080/14737140.2024.2326575. Online ahead of print.ABSTRACTINTRODUCTION: Triple-negative breast cancer (TNBC) continues to be a significant concern, especially among minority populations, where treatment disparities are notably pronounced. Addressing these disparities, especially among African American women and other minorities, is crucial for ensuring equitable healthcare.AREAS COVERED: This review delves into the continuum of TNBC treatment, noting that the standard of care, previously restricted to chemotherapy, has now expanded due to emerging clinical trial results. With...
Source: Expert Review of Anticancer Therapy - March 4, 2024 Category: Cancer & Oncology Authors: Zouina Sarfraz Azza Sarfraz Onaiza Mehak Ramsha Akhund Shehar Bano Hinna Aftab Source Type: research
Efficacy and safety of neoadjuvant combination immunotherapy in surgically resectable malignant solid tumors: a systematic review and meta-analysis
CONCLUSION: This study demonstrated the efficacy of neoadjuvant combination immunotherapy. Given that the majority of the included trials were phase II with small sample sizes, further multicenter phase III randomized controlled trials should be conducted to validate the findings of the review.PMID:38436076 | DOI:10.1080/14737140.2024.2325404 (Source: Expert Review of Anticancer Therapy)
Source: Expert Review of Anticancer Therapy - March 4, 2024 Category: Cancer & Oncology Authors: Yuqian Feng Kaibo Guo Huimin Jin Jing Jiang Menglei Wang Shengyou Lin Source Type: research
Racial and socioeconomic disparities in triple-negative breast cancer treatment
Expert Rev Anticancer Ther. 2024 Mar 4. doi: 10.1080/14737140.2024.2326575. Online ahead of print.ABSTRACTINTRODUCTION: Triple-negative breast cancer (TNBC) continues to be a significant concern, especially among minority populations, where treatment disparities are notably pronounced. Addressing these disparities, especially among African American women and other minorities, is crucial for ensuring equitable healthcare.AREAS COVERED: This review delves into the continuum of TNBC treatment, noting that the standard of care, previously restricted to chemotherapy, has now expanded due to emerging clinical trial results. With...
Source: Expert Review of Anticancer Therapy - March 4, 2024 Category: Cancer & Oncology Authors: Zouina Sarfraz Azza Sarfraz Onaiza Mehak Ramsha Akhund Shehar Bano Hinna Aftab Source Type: research
Efficacy and safety of neoadjuvant combination immunotherapy in surgically resectable malignant solid tumors: a systematic review and meta-analysis
CONCLUSION: This study demonstrated the efficacy of neoadjuvant combination immunotherapy. Given that the majority of the included trials were phase II with small sample sizes, further multicenter phase III randomized controlled trials should be conducted to validate the findings of the review.PMID:38436076 | DOI:10.1080/14737140.2024.2325404 (Source: Expert Review of Anticancer Therapy)
Source: Expert Review of Anticancer Therapy - March 4, 2024 Category: Cancer & Oncology Authors: Yuqian Feng Kaibo Guo Huimin Jin Jing Jiang Menglei Wang Shengyou Lin Source Type: research
Racial and socioeconomic disparities in triple-negative breast cancer treatment
Expert Rev Anticancer Ther. 2024 Mar 4. doi: 10.1080/14737140.2024.2326575. Online ahead of print.ABSTRACTINTRODUCTION: Triple-negative breast cancer (TNBC) continues to be a significant concern, especially among minority populations, where treatment disparities are notably pronounced. Addressing these disparities, especially among African American women and other minorities, is crucial for ensuring equitable healthcare.AREAS COVERED: This review delves into the continuum of TNBC treatment, noting that the standard of care, previously restricted to chemotherapy, has now expanded due to emerging clinical trial results. With...
Source: Expert Review of Anticancer Therapy - March 4, 2024 Category: Cancer & Oncology Authors: Zouina Sarfraz Azza Sarfraz Onaiza Mehak Ramsha Akhund Shehar Bano Hinna Aftab Source Type: research
Efficacy and safety of neoadjuvant combination immunotherapy in surgically resectable malignant solid tumors: a systematic review and meta-analysis
CONCLUSION: This study demonstrated the efficacy of neoadjuvant combination immunotherapy. Given that the majority of the included trials were phase II with small sample sizes, further multicenter phase III randomized controlled trials should be conducted to validate the findings of the review.PMID:38436076 | DOI:10.1080/14737140.2024.2325404 (Source: Expert Review of Anticancer Therapy)
Source: Expert Review of Anticancer Therapy - March 4, 2024 Category: Cancer & Oncology Authors: Yuqian Feng Kaibo Guo Huimin Jin Jing Jiang Menglei Wang Shengyou Lin Source Type: research
Molecular subtype identification and prognosis stratification by a immunogenic cell death-related gene expression signature in colorectal cancer
CONCLUSIONS: This study constructed and validated the ICD feature signature predicting CRC prognosis and provide a reference criteria for guiding the prognosis and immunotherapy of CRC cancer patients.PMID:38407877 | DOI:10.1080/14737140.2024.2320187 (Source: Expert Review of Anticancer Therapy)
Source: Expert Review of Anticancer Therapy - February 26, 2024 Category: Cancer & Oncology Authors: Junping Lei Jia Fu Tianyang Wang Yu Guo Mingmin Gong Tian Xia Song Shang Yan Xu Ling Cheng Binghu Lin Source Type: research
Development and validation of survival nomograms in elder triple-negative invasive ductal breast carcinoma patients
CONCLUSION: The proposed nomogram provides a convenient and reliable tool for individual evaluations for elderly patients with M0_stage TNIDC. However, the model may only for Americans.PMID:38366359 | DOI:10.1080/14737140.2024.2320815 (Source: Expert Review of Anticancer Therapy)
Source: Expert Review of Anticancer Therapy - February 17, 2024 Category: Cancer & Oncology Authors: Tao Jiang Sha Yang Guanghui Wang Ying Tan Shu Liu Source Type: research
